Intervenants:
Pr. Denis Vivien, INSERM, Physiopathology and Imaging of Neurological Disorders, Caen
Dr. Nicolas Violle, ETAP-Lab, Vandoeuvre-lès-Nancy
Pr. Fernando Pico, INSERM, Laboratory for Vascular Translational Science, Paris
Pr. Mathieu Zuber, INSERM, Physiopathology and Imaging of Neurological Disorders, Caen
Pr. Thomas Gaberel, INSERM, Physiopathology and Imaging of Neurological Disorders, Caen
Pr. Michael Mazighi, INSERM, Laboratory for Vascular Translational Science, Paris
Abstract:
Launch of STROK@LLIANCE, the new preclinical platform resulting from the alliance of the public Experimental Stroke Research Platform (ESRP) and the well-established CRO ETAP-Lab.
For half a day, neurologists, neuroradiologists, neurosurgeons, researchers, specialists in preclinical and clinical trials, will give you an overview of stroke etiology, current acute management practices and animal modeling. Next, they will discuss with you during a debate: « The transition from preclinical drug to clinical drug for stroke: What are the essential information for clinicians about pharmacology issues? »
